UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

Status of newborn screening programs in the United States

Pediatrics (Evanston), 2006-05, Vol.117 (5 Pt 2), p.S212

2006

Volltextzugriff (PDF)

NEWBORN SCREENING FOR CONGENITAL ADRENAL HYPERPLASIA

Endocrinology and metabolism clinics of North America, 2001-03, Vol.30 (1), p.15-30

Therrell, Bradford L.

2001

Volltextzugriff (PDF)

Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening

Genetics in medicine, 2011-07, Vol.13 (7), p.621-624

2011

Volltextzugriff (PDF)

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia

Pediatrics (Evanston), 1998-04, Vol.101 (4 Pt 1), p.583

1998

Volltextzugriff (PDF)

U.S. Newborn Screening Policy Dilemmas for the Twenty-First Century

Molecular Genetics and Metabolism, 2001-09, Vol.74 (1-2), p.64-74

Therrell, Bradford L.

2001

Volltextzugriff (PDF)

Demographic Risk Factors Associated with Elevated Lead Levels in Texas Children Covered by Medicaid

Environmental health perspectives, 1997-01, Vol.105 (1), p.66-68

1997

Volltextzugriff (PDF)

Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology

The journal of clinical endocrinology and metabolism, 2002-09, Vol.87 (9), p.4048-4053

2002

Volltextzugriff (PDF)

Naming and counting disorders (conditions) included in newborn screening panels

Pediatrics (Evanston), 2006-05, Vol.117 (5 Pt 2), p.S308

2006

Volltextzugriff (PDF)

Newborn screening: rationale for a comprehensive, fully integrated public health system

Molecular Genetics and Metabolism, 2002-12, Vol.77 (4), p.267-273

2002

Volltextzugriff (PDF)

Financing state newborn screening programs: sources and uses of funds

Pediatrics (Evanston), 2006-05, Vol.117 (5 Pt 2), p.S270

2006

Volltextzugriff (PDF)

Newborn Screening: The Role of the Obstetrician

Clinical obstetrics and gynecology, 2002-09, Vol.45 (3), p.697-710

2002

Volltextzugriff (PDF)

Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society

Hormone research, 2002, Vol.58 (4), p.188-195

2002

Volltextzugriff (PDF)

Understanding Newborn Screening System Issues With Emphasis on Cystic Fibrosis Screening

The Journal of pediatrics, 2005-09, Vol.147 (3), p.S6-S10

2005

Volltextzugriff (PDF)

Assuring clinical genetic services for newborns identified through U.S. newborn screening programs

Genetics in medicine, 2007-08, Vol.9 (8), p.518-527

2007

Volltextzugriff (PDF)

DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up

The Journal of pediatrics, 2003-03, Vol.142 (3), p.346-348

2003

Volltextzugriff (PDF)

A Comparative Cost Analysis of Newborn Screening for Classic Congenital Adrenal Hyperplasia in Texas

Public health reports (1974), 1998-03, Vol.113 (2), p.170-178

1998

Volltextzugriff (PDF)

Neuroblastoma screening in the United States: Results of the Texas outreach program for neuroblastoma screening

Cancer, 1998-04, Vol.82 (8), p.1593-1602

1998

Volltextzugriff (PDF)

An evaluation of kits for measuring thyrotropin in newborns

Clinical chemistry (Baltimore, Md.), 1984-11, Vol.30 (11), p.1854

1984

Volltextzugriff (PDF)

Analysis for lead in undiluted whole blood by tantalum ribbon atomic absorption spectrophotometry

Clinical chemistry (Baltimore, Md.), 1978-07, Vol.24 (7), p.1182

1978

Volltextzugriff (PDF)

Genotypic confirmation from the original dried blood specimens in a neonatal hemoglobinopathy screening program

Pediatric research, 1992-03, Vol.31 (3), p.217-221

1992

Volltextzugriff (PDF)

Multivariant Confirmation of Sickle Cell Disease Using a Non-Radioactive Minisequencing Reaction

Hemoglobin, 1997, Vol.21 (1), p.71-89

1997

Volltextzugriff (PDF)

Experiences with sickle hemoglobin testing in the Texas Newborn Screening Program

Pediatrics (Evanston), 1989-05, Vol.83 (5 Pt 2), p.864

1989

Volltextzugriff (PDF)

Unbiased analysis of the frequency of beta-thalassemia point mutations in a population of African-American newborns

Archives of pathology & laboratory medicine (1976), 1993-11, Vol.117 (11), p.1110

1993

Volltextzugriff (PDF)

Molecular Genetics of 21-Hydroxylase Deficient Late-Onset Adrenal Hyperplasia

Seminars in reproductive medicine, 1993-11, Vol.11 (4), p.347-352

1993

Volltextzugriff (PDF)

Rapid detection of beta s DNA from Guthrie cards by chromogenic probes

The Lancet (British edition), 1989-09, Vol.2 (8665), p.741-741

1989

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(39)
magazinearticle
(1)

Sprache

Englisch
(40)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(39)
Life Sciences & Biomedicine
(38)
Humans
(36)
Infant, Newborn
(24)
Pediatrics
(12)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Biochemistry & Molecular Biology
(8)
Female
(8)
United States
(8)
Neonatal Screening
(7)
Newborn Screening
(7)
Endocrinology & Metabolism
(6)
Medicine, Research & Experimental
(6)
Neonatal Screening - Methods
(6)
Research & Experimental Medicine
(6)
Texas
(6)
Adrenal Hyperplasia, Congenital - Diagnosis
(5)
Male
(5)
Public Health
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Status of newborn screening programs in the United States

NEWBORN SCREENING FOR CONGENITAL ADRENAL HYPERPLASIA

Committee report: Considerations and recommendations for national guidance regarding the retention and use of residual dried blood spot specimens after newborn screening

Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia

U.S. Newborn Screening Policy Dilemmas for the Twenty-First Century

Demographic Risk Factors Associated with Elevated Lead Levels in Texas Children Covered by Medicaid

Consensus Statement on 21-Hydroxylase Deficiency from The Lawson Wilkins Pediatric Endocrine Society and The European Society for Paediatric Endocrinology

Naming and counting disorders (conditions) included in newborn screening panels

Newborn screening: rationale for a comprehensive, fully integrated public health system

Financing state newborn screening programs: sources and uses of funds

Newborn Screening: The Role of the Obstetrician

Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society

Understanding Newborn Screening System Issues With Emphasis on Cystic Fibrosis Screening

Assuring clinical genetic services for newborns identified through U.S. newborn screening programs

DNA diagnosis confirms hemoglobin deletion in newborn screen follow-up

A Comparative Cost Analysis of Newborn Screening for Classic Congenital Adrenal Hyperplasia in Texas

Neuroblastoma screening in the United States: Results of the Texas outreach program for neuroblastoma screening

An evaluation of kits for measuring thyrotropin in newborns

Analysis for lead in undiluted whole blood by tantalum ribbon atomic absorption spectrophotometry

Genotypic confirmation from the original dried blood specimens in a neonatal hemoglobinopathy screening program

Multivariant Confirmation of Sickle Cell Disease Using a Non-Radioactive Minisequencing Reaction

Experiences with sickle hemoglobin testing in the Texas Newborn Screening Program

Unbiased analysis of the frequency of beta-thalassemia point mutations in a population of African-American newborns

Molecular Genetics of 21-Hydroxylase Deficient Late-Onset Adrenal Hyperplasia

Rapid detection of beta s DNA from Guthrie cards by chromogenic probes

Suchergebnisse filtern